Summary
"The US Food and Drug Administration is creating a new position at the Office of FDA's Chief Scientist that will focus on the agency's genomics-related programs, FDA said this week."
Analysis
Future appraisals MAY be dependent on Genomic considerations in studies that are used for FDA approval of therapeutic agents!
This author consults with leading institutions through GLG
Analyses are solely the work of the authors and have not been edited or endorsed by GLG.
